Fecal microbiota transplantation: Uses, questions, and ethics
Fecal microbiota transplantation (FMT) has rapidly grown in notoriety and popularity worldwide as a treatment for both recurrent and refractory C. difficile infection (CDI), as well as for a myriad of other indications, with varying levels of evidence to justify its use. At present, FMT use in the U...
Main Authors: | Zoya Grigoryan, Michael J. Shen, Shaina W. Twardus, Marc M. Beuttler, Lea Ann Chen, Alison Bateman-House |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Medicine in Microecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590097820300240 |
Similar Items
-
Fecal Microbiota Transplantation for Refractory and Recurrent Clostridium difficile Infection: A Case Series of Nine Patients
by: Byoung Wook Bang, et al.
Published: (2017-04-01) -
The human gut micro biome and future role of fecal microbiota transplants
by: Dwyer, Daniel P.
Published: (2016) -
Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
by: Shaaz Fareed, et al.
Published: (2018-05-01) -
The use of fecal microbiota transplantation in the treatment of intestinal diseases
by: Gabriela Ręka, et al.
Published: (2020-09-01) -
Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)